1-12 of 12
R Hehlmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of a Combination of Imatinib and Pegylated Interferon α2a (Pegasys®) in Newly Diagnosed Patients with Chronic Myelogenous Leukemia - A Phase II Cohort Study.

Andreas Hochhaus, MD, A. Neubauer, MD, M.C. Mueller, MD, T. Fischer, MD, C. Waller, MD, T.H. Bruemmendorf, MD, T. Bostel, C. Lengerke, MD, R. Hehlmann, MD, A. Burchert, MD
Journal: Blood
Blood (2007) 110 (11): 1027.
https://doi.org/10.1182/blood.V110.11.1027.1027
Published: 2007
Journal Articles

Sensitive Detection of FIP1L1-PDGFRA Fusion Transcripts by Real-Time Quantitative RT-PCR (RQ-PCR) Reveals Achievement of Molecular Remission in Chronic Eosinophilic Leukemia Treated with Low-Dose Imatinib Therapy.

J. Jovanovic, A. Reiter, D. Cilloni, E. Gottardi, J. Score, H. Popp, G. Metzgeroth, C. Walz, A. Hochhaus, C. Roche, C. Preudhomme, M. Rondoni, E. Ottaviani, F. Rancati, E. Solomon, J. Apperley, G. Martinelli, G. Saglio, R. Hehlmann, N. C.P. Cross, D. Grimwade
Journal: Blood
Blood (2005) 106 (11): 483.
https://doi.org/10.1182/blood.V106.11.483.483
Published: 2005
Journal Articles

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Enrico Gottardi, Daniela Cilloni, MD, Sarah Daly, S. Green, Niels Pallisgaard, P. Hokland, MD, M. Ostergaard, C. Nyvold, J. Nomdedeu, MD, Fabrizio Pane, MD, Susanne Schnittger, Vincent Van der Velden, Kalid Tobal, Y. Yin Jal, Fabienne Hermitte, Teo De Witte, R. Hehlmann, Giuseppe Saglio, MD, David Grimwade, MD
Journal: Blood
Blood (2005) 106 (11): 3295.
https://doi.org/10.1182/blood.V106.11.3295.3295
Published: 2005
Journal Articles

Long Term Observation of CML Patients after Imatinib Resistance Associated with BCR-ABL Mutations.

Andreas Hochhaus, MD, T. Ernst, MD, P. Erben, MD, M. C. Mueller, MD, M. Emig, MD, S. Kreil, MD, P. La Rosée, MD, T. Lahaye, MD, M. Schatz, MD, O. G. Ottmann, MD, S. Schnittger, PhD, U. Berger, MD, R. Hehlmann, MD
Journal: Blood
Blood (2005) 106 (11): 1086.
https://doi.org/10.1182/blood.V106.11.1086.1086
Published: 2005
Journal Articles

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Martin C. Mueller, MD, P. Paschka, MD, T. Lahaye, MD, Ch. Lorentz, MD, N. Gattermann, MD, D. Niederwieser, MD, G. Ehninger, MD, St Fruehauf, MD, A. Neubauer, MD, Th. Fischer, MD, B. Schultheis, MD, S. Kreil, MD, U. Haus, PhD, R. Hehlmann, MD, A. Hochhaus, MD, the German CML Study Group
Journal: Blood
Blood (2004) 104 (11): 1003.
https://doi.org/10.1182/blood.V104.11.1003.1003
Published: 2004
Journal Articles

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

A Hochhaus, A Reiter, H Skladny, JV Melo, C Sick, U Berger, JQ Guo, RB Arlinghaus, R Hehlmann, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 88 (6): 2236–2240.
https://doi.org/10.1182/blood.V88.6.2236.bloodjournal8862236
Published: 1996
Journal Articles

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

J Hasford, M Baccarani, R Hehlmann, H Anseri, S Tura, E Zuffa
Journal: Blood
Blood (1996) 87 (12): 5384–5391.
https://doi.org/10.1182/blood.V87.12.5384.bloodjournal87125384
Published: 1996
Journal Articles

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

A Hochhaus, F Lin, A Reiter, H Skladny, PJ Mason, F van Rhee, PC Shepherd, NC Allan, R Hehlmann, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 87 (4): 1549–1555.
https://doi.org/10.1182/blood.V87.4.1549.bloodjournal8741549
Published: 1996
Journal Articles

Randomized Comparison of Interferon-{alpha}, Hydroxyurea, and Busulfan in Chronic Myeloid Leukemia: Response to Kantarjian and Talpaz and to Tura and Baccarani

R. Hehlmann, H. Heimpel, J. Hasford
Journal: Blood
Blood (1995) 85 (10): 3000–3002.
https://doi.org/10.1182/blood.V85.10.3000.bloodjournal85103000
Published: 1995
Journal Articles

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, A Hochhaus, B Heinze
Journal: Blood
Blood (1994) 84 (12): 4064–4077.
https://doi.org/10.1182/blood.V84.12.4064.bloodjournal84124064
Published: 1994
Journal Articles

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group

R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, B Heinze, A Georgii
Journal: Blood
Blood (1993) 82 (2): 398–407.
https://doi.org/10.1182/blood.V82.2.398.398
Published: 1993
Journal Articles

Zinc protoporphyrin in anemia of chronic disorders

J Hastka, JJ Lasserre, A Schwarzbeck, M Strauch, R Hehlmann
Journal: Blood
Blood (1993) 81 (5): 1200–1204.
https://doi.org/10.1182/blood.V81.5.1200.1200
Published: 1993